Sunitinib malate
USP/1642358 - United States Pharmacopeia (USP) Reference Standard
Synonym: N-
CAS Number: 341031-54-7
Empirical Formula (Hill Notation): C22H27FN4O2 · C4H6O5
Molecular Weight: 532.56
MDL Number: MFCD08282795
Linear Formula: C22H27FN4O2 · C4H6O5
Product Type: Chemical
agency | USP |
application(s) | pharmaceutical |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C22H27FN4O2.C4H6O5/c1- |
InChI key | LBWFXVZLPYTWQI-IPOVEDGCSA |
manufacturer/tradename | USP |
packaging | pkg of 200 mg |
SMILES string | O[C@@H](CC(O)=O)C(O)=O.CC |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Biochem/physiol Actions: | Sunitinib malate is a receptor tyrosine kinase inhibitor, which targets VEGF-R1, VEGF-R2, VEGF-R3, PDGF-Rα, PDGF-Rβ, KIT, FLT3, CSF-1R, and RET. Sunitinib malate is an anticancer drug. |
General description: | This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. |
Other Notes: | Sales restrictions may apply. |
Other Notes: | USP issued SDS can be found here . |
UNSPSC | 41116107 |